These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Divergence in activation by poly I:C of human natural killer and killer cells. Edwards BS; Borden EC; Smith-Zaremba K Cancer Immunol Immunother; 1982; 13(3):158-63. PubMed ID: 6925981 [TBL] [Abstract][Full Text] [Related]
9. Azathioprine suppression of natural killer activity and antibody-dependent cellular cytotoxicity in renal transplant recipients. Prince HE; Ettenger RB; Dorey FJ; Fine RN; Fahey JL J Clin Immunol; 1984 Jul; 4(4):312-8. PubMed ID: 6378956 [TBL] [Abstract][Full Text] [Related]
10. Effect of various interferons on the spontaneous cytotoxicity exerted by lymphocytes from normal and tumor-bearing patients. Lucero MA; Fridman WH; Provost MA; Billardon C; Pouillart P; Dumont J; Falcoff E Cancer Res; 1981 Jan; 41(1):294-9. PubMed ID: 6160906 [TBL] [Abstract][Full Text] [Related]
12. Phorbol esters enhance spontaneous cytotoxicity of human lymphocytes, abrogate Fc receptor expression, and inhibit antibody-dependent lymphocyte-mediated cytotoxicity. Trinchieri G; O'Brien T; Shade M; Perussia B J Immunol; 1984 Oct; 133(4):1869-77. PubMed ID: 6432902 [TBL] [Abstract][Full Text] [Related]
13. Immunomodulatory effects of corticosteroids on natural killer and antibody-dependent cellular cytotoxic activities of human lymphocytes. Nair MP; Schwartz SA J Immunol; 1984 Jun; 132(6):2876-82. PubMed ID: 6202765 [TBL] [Abstract][Full Text] [Related]
14. The effect of long-term cyclosporine therapy on natural killer cell activity. Versluis DJ; Metselaar HJ; Bijma AM; Vaessen LM; Wenting GJ; Weimar W Transplant Proc; 1988 Apr; 20(2 Suppl 2):179-85. PubMed ID: 3129839 [No Abstract] [Full Text] [Related]
15. Effect of morphine and beta-endorphin on human Fc receptor-dependent and natural killer cell functions. Yeager MP; Yu CT; Campbell AS; Moschella M; Guyre PM Clin Immunol Immunopathol; 1992 Mar; 62(3):336-43. PubMed ID: 1541057 [TBL] [Abstract][Full Text] [Related]
16. Metabolic requirements for the in vitro augmentation of mouse natural killer activity by interferon. Djeu JY; Stocks N; Varesio L; Holden HT; Herberman RB Cell Immunol; 1981 Feb; 58(1):49-60. PubMed ID: 6164493 [No Abstract] [Full Text] [Related]
17. Etretinate therapy and immune activities. Kang S; Ellis CN; Grekin RC; Hamilton TA; Voorhees JJ; LoBuglio AF Arch Dermatol; 1986 Jun; 122(6):629-30. PubMed ID: 3717974 [No Abstract] [Full Text] [Related]
18. Effects of levamisole on human natural killer and killer cell activity and production of interferons. Liberati M; Borden EC; McBain JA; Raubertas R Immunopharmacology; 1982 Oct; 5(1):11-8. PubMed ID: 6182126 [TBL] [Abstract][Full Text] [Related]
19. The role of interferon-gamma in the immunotherapy of neuroblastoma. Handgretinger R; Bruchelt G; Daurer B; Lang P; Herter M; Dopfer R; Müller B; Reisfeld RA; Treuner J; Niethammer D Prog Clin Biol Res; 1991; 366():401-7. PubMed ID: 1906184 [No Abstract] [Full Text] [Related]